Therapeutic approaches targeting the prion receptor LRP/LR

Veterinary Microbiology

Volumn 123, Issue 4, 2007, Pages 387-393

  Zuber, Chantal ^a   Ludewigs, Heike ^a   Weiss, Stefan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

37 kDa 67 kDa laminin receptor; Bovine spongiform encephalopathy; LRP LR; Prion; PrP; Therapy; Transmissible spongiform encephalopathy

Indexed keywords

4' IODOESORUBICIN; CELLULAR PRION PROTEIN; CHLORPROMAZINE; COMPLEMENTARY RNA; CONGO RED; FLUPIRTINE; ISOPROTEIN; LAMININ RECEPTOR PRECURSOR; MEPACRINE; MONOCLONAL ANTIBODY; POLYANION; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY W3; PRION PROTEIN; RECEPTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TETRAPYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN DEGENERATION; CREUTZFELDT JAKOB DISEASE; DRUG EFFECT; DRUG EFFICACY; HUMAN; NONHUMAN; PRION DISEASE; PROTEIN FOLDING; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; MOLECULAR WEIGHT; PRION DISEASES; PRIONS; PROTEIN PRECURSORS; RECEPTORS, LAMININ;

ANIMALIA; BOVINAE;

EID: 34447650047     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.04.005     Document Type: Article

References (51)

1. Akache B., Grimm D., Pandey K., Stephen R.Y., Xu H., and Kay M.A. The 37/67-Kilodalton Laminin Receptor is a receptor for Adeno-Associated Virus Serotypes 8,2,3, and 9. J. Virol. 80 (2006) 9831-9836
2. Ardini E., Pesole G., Tagliabue E., Magnifico A., Castronovo V., Sobel M.E., Colnaghi M.I., and Menard S. The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. Mol. Biol. Evol. 15 (1998) 1017-1025
3. Auth D., and Brawerman G. A 33-kDa polypeptide with homology to the laminin receptor: component of translation machinery. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4368-4372
4. Baloui H., von Boxberg Y., Vinh J., Weiss S., Rossier J., Nothias F., and Stettler O. Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neurons. Eur. J. Neurosci. 20 (2004) 2605-2616
5. Barret A., Tagliavini F., Forloni G., Bate C., Salmona M., Colombo L., De Luigi A., Limido L., Suardi S., Rossi G., Auvre F., Adjou K.T., Sales N., Williams A., Lasmezas C., and Deslys J.P. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77 (2003) 8462-8469
6. Benestad S.L., Sarradin P., Thu B., Schonheit J., Tranulis M.A., and Bratberg B. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet. Rec. 153 (2003) 202-208
7. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., and Bostock C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 (1997) 498-501
8. Buchholz C.J., Bach P., Nikles D., and Kalinke U. Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies. Expert. Opin. Biol. Ther. 6 (2006) 293-300
9. Castronovo V., Taraboletti G., and Sobel M.E. Functional domains of the 67-kDa laminin receptor precursor. J. Biol. Chem. 266 (1991) 20440-20446
10. Cohen F.E., and Prusiner S.B. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67 (1998) 793-819
11. Daude N., Marella M., and Chabry J. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J. Cell Sci. 116 (2003) 2775-2779
12. Demaimay R., Adjou K.T., Beringue V., Demart S., Lasmezas C.I., Deslys J.P., Seman M., and Dormont D. Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J. Virol. 71 (1997) 9685-9689
13. Donofrio G., Heppner F.L., Polymenidou M., Musahl C., and Aguzzi A. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J. Virol. 79 (2005) 8330-8338
14. Enari M., Flechsig E., and Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9259-9299
15. Farquhar C.F., and Dickinson A.G. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J. Gen. Virol. 67 Pt 3 (1986) 463-473
16. Gauczynski S., Nikles D., El-Gogo S., Papy-Garcia D., Rey C., Alban S., Barritault D., Lasmezas C.I., and Weiss S. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Infect. Dis. 194 (2006) 702-709
17. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J.P., Dormont D., Lasmezas C.I., and Weiss S. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20 (2001) 5863-5875
18. Heppner F.L., Christ A.D., Klein M.A., Prinz M., Fried M., Kraehenbuhl J.P., and Aguzzi A. Transepithelial prion transport by M cells. Nat. Med. 7 (2001) 976-977
19. Hijazi N., Kariv-Inbal Z., Gasset M., and Gabizon R. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J. Biol. Chem. 280 (2005) 17057-17061
20. Horonchik L., Tzaban S., Ben-Zaken O., Yedidia Y., Rouvinski A., Papy-Garcia D., Barritault D., Vlodavsky I., and Taraboulos A. Heparan sulfate is a cellular receptor for purified infectious prions. J. Biol. Chem. 280 (2005) 17062-17067
21. Hundt C., Peyrin J.M., Haik S., Gauczynski S., Leucht C., Rieger R., Riley M.L., Deslys J.P., Dormont D., Lasmezas C.I., and Weiss S. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 20 (2001) 5876-5886
22. Ingrosso L., Ladogana A., and Pocchiari M. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69 (1995) 506-508
23. Kinoshita K., Kaneda Y., Sato M., Saeki Y., Wataya-Kaneda M., and Hoffmann A. LBP-p40 binds DNA tightly through associations with histones H2A, H2B, and H4. Biochem. Biophys. Res. Commun. 253 (1998) 277-282
24. Korth C., May B.C., Cohen F.E., and Prusiner S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9836-9841
25. Leucht C., Simoneau S., Rey C., Vana K., Rieger R., Lasmezas C.I., and Weiss S. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4 (2003) 290-295
26. Ludwig G.V., Kondig J.P., and Smith J.F. A putative receptor for Venezuelan equine encephalitis virus from mosquito cells. J. Virol. 70 (1996) 5592-5599
27. Makrides S., Chitpatima S.T., Bandyopadhyay R., and Brawerman G. Nucleotide sequence for a major messenger RNA for a 40 kilodalton polypeptide that is under translational control in mouse tumor cells. Nucleic Acids Res. 16 (1988) 2349
28. Morel E., Andrieu T., Casagrande F., Gauczynski S., Weiss S., Grassi J., Rousset M., Dormont D., and Chambaz J. Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am. J. Pathol. 167 (2005) 1033-1042
29. Otto M., Cepek L., Ratzka P., Doehlinger S., Boekhoff I., Wiltfang J., Irle E., Pergande G., Ellers-Lenz B., Windl O., Kretzschmar H.A., Poser S., and Prange H. Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 62 (2004) 714-718
30. Pankiewicz J., Prelli F., Sy M.S., Kascsak R.J., Kascsak R.B., Spinner D.S., Carp R.I., Meeker H.C., Sadowski M., and Wisniewski T. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neurosci. 23 (2006) 2635-2647
31. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., and Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412 (2001) 739-743
32. Perrier V., Solassol J., Crozet C., Frobert Y., Mourton-Gilles C., Grassi J., and Lehmann S. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPc degradation. J. Neurochem. 89 (2004) 454-463
33. Pfeifer A., Eigenbrod S., Al-Khadra S., Hofmann A., Mitteregger G., Moser M., Bertsch U., and Kretzschma H. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J. Clin. Invest. 116 (2006) 3204-3210
34. Priola S.A., Raines A., and Caughey W.S. Porphyrin and phthalocyanine antiscrapie compounds. Science 287 (2000) 1503-1506
35. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
36. Ralph G.S., Radcliffe P.A., Day D.M., Carthy J.M., Leroux M.A., Lee D.C., Wong L.F., Bilsland L.G., Greensmith L., Kingsman S.M., Mitrophanous K.A., Mazarakis N.D., and Azzouz M. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11 (2005) 429-433
37. Rao N.C., Barsky S.H., Terranova V.P., and Liotta L.A. Isolation of a tumor cell laminin receptor. Biochem. Biophys. Res. Commun. 111 (1983) 804-808
38. Raoul C., Abbas-Terki T., Bensadoun J.C., Guillot S., Haase G., Szulc J., Henderson C.E., and Aebischer P. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat. Med. 11 (2005) 423-428
39. Rieger R., Edenhofer F., Lasmezas C.I., and Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3 (1997) 1383-1388
40. Roikhel V.M., Fokina G.I., and Pogodina V.V. Influence of aminasine on experimental scrapie in mice. Acta Virol. 28 (1984) 321-324
41. Romanov V., Sobel M.E., pinto da Silva P., Menard S., and Castronovo V. Cell localization and redistribution of the 67 kD laminin receptor and alpha 6 beta 1 integrin subunits in response to laminin stimulation: an immunogold electron microscopy study. Cell Adhes. Commun. 2 (1994) 201-209
42. Sato M., Kinoshita K., Kaneda Y., Saeki Y., Iwamatsu A., and Tanaka K. Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40). Biochem. Biophys. Res. Commun. 229 (1996) 896-901
43. Shmakov A.N., Bode J., Kilshaw P.J., and Ghosh S. Diverse patterns of expression of the 67-kD laminin receptor in human small intestinal mucosa: potential binding sites for prion proteins?. J. Pathol. 191 (2000) 318-322
44. Simoneau S., Haik S., Leucht C., Dormont D., Deslys J.P., Weiss S., and Lasmezas C. Different isoforms of the non-integrin laminin receptor are present in mouse brain and bind PrP. Biol. Chem. 384 (2003) 243-246
45. Tagliavini F., McArthur R.A., Canciani B., Giaccone G., Porro M., Bugiani M., Lievens P.M., Bugiani O., Peri E., Dall'Ara P., Rocchi M., Poli G., Forloni G., Bandiera T., Varasi M., Suarato A., Cassutti P., Cervini M.A., Lansen J., Salmona M., and Post C. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276 (1997) 1119-1122
46. Tio P.H., Jong W.W., and Cardosa M.J. Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3. Virol. J. 2 (2005) 25
47. Vana K., and Weiss S. A trans-dominant negative 37 kDa/67 kDa laminin receptor mutant impairs PrPSc propagation in scrapie-infected neuronal cells. J. Mol. Biol. 358 (2006) 57-66
48. Wang K.S., Kuhn R.J., Strauss E.G., Ou S., and Strauss J.H. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66 (1992) 4992-5001
49. Wells G.A., Hawkins S.A., Austin A.R., Ryder S.J., Done S.H., Green R.B., Dexter I., Dawson M., and Kimberlin R.H. Studies of the transmissibility of the agent of bovine spongiform encephalopathy to pigs. J. Gen. Virol. 84 (2003) 1021-1031
50. White A.R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., Anstee D., Collinge J., and Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422 (2003) 80-83
51. Zuber, C., Knackmuss, S., Rey, C., Reusch, U., Röttgen, P., Fröhlich, T., Arnold, G., Mitteregger, G., Pace, C., Kretzschmar, H.A., Little, M., Weiss, S., 2007. Single chain Fv antibodies directed against the 37kDa/67kDa laminin receptor as therapeutic tools in prion diseases. Mol. Imm., in press.